MHRA updates advice for osteoporosis drug use
Healthcare professionals treating severe osteoporosis in women who have gone through the menopause and men with a high risk of fracture are to be given updated advice on the use of Protelos.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units